Officials in the United Arab Emirates are reporting encouraging results from phase-three trials of a Chinese vaccine. Meanwhile, in its late-stage trials, pharmaceutical giant Pfizer says participants have shown mild-to-moderate symptoms from its vaccine. Timothy Ulrich takes a look at the latest on the race to create a vaccine.